- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 223/20 - Dibenz [b, e] azepinesHydrogenated dibenz [b, e] azepines
Patent holdings for IPC class C07D 223/20
Total number of patents in this class: 21
10-year publication summary
|
2
|
2
|
3
|
2
|
2
|
1
|
0
|
1
|
0
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Janssen Pharmaceutica N.V. | 3589 |
2 |
| Assembly Biosciences, Inc. | 71 |
2 |
| Indiana University Research and Technology Corporation | 796 |
2 |
| Contineum Therapeutics, Inc. | 14 |
2 |
| University of Southern California | 2084 |
1 |
| Cellixbio Private Limited | 167 |
1 |
| Cnrs | 103 |
1 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3365 |
1 |
| Research Triangle Institute | 407 |
1 |
| Universite Grenoble Alpes | 703 |
1 |
| The University of Bristol | 243 |
1 |
| Tiumbio Co., Ltd. | 23 |
1 |
| Valentek LLC | 1 |
1 |
| Yamo Pharmaceuticals LLC | 21 |
1 |
| Limited Liability Company "valentek" | 2 |
1 |
| Obschestvo S Ogranichennoy Otvetstvennostyou "valentek" | 1 |
1 |
| Alairion, Inc. | 6 |
1 |
| Other owners | 0 |